The FDA is set to refocus its efforts in combating the United States’ opioid crisis. Speaking at a meeting of the National Governor’s Association on the weekend, Health and Human Services Secretary Alex Azar announced that the agency will soon release guidance to expand access to medication-assisted treatment (MAT), a combination of behavioural therapy and medication to reduce cravings and withdrawals from opioid use.
FDA to fight opioid crisis with wider access to medication-assisted treatment
